Weekend Wonderings

Written April 19th, 2014 by Ken

th_chimpWelcome to this week’s edition of Weekend Wonderings. I hope that you have a nice, enjoyable Easter weekend and get ample “family” time. So, if you’re reading this on Sunday, I appreciate it, but get back to your family. You can catch this later Sunday or Monday.. Oh, and if you’re visiting, safe travels to you. Regardless, grab whatever beverage that you need and let’s proceed.

The James/Wexner

Study Identifies a Likely Key Driver of Colorectal Cancer Development and Progression

  • New targets are needed for agents that will more effectively treat colorectal cancer.
  • This study identifies a molecule that is probably a key driver of colorectal cancer.
  • The findings strongly suggest that this molecule could be an important therapeutic target and a valuable biomarker of colorectal cancer tumor progression.

A new study identifies a molecule that is a probable driving force in colorectal cancer and suggests that the molecule could be an important target for colorectal cancer treatment and a valuable biomarker of tumor progression.

“We found that miR-135b is up-regulated in both sporadic and inflammatory bowel disease-associated colorectal cancer, and that its up-regulation is associated with tumor stage and poor clinical outcome,” says principal investigator Carlo M. Croce, MD, chair of molecular virology, immunology and medical genetics, and director of Human Cancer Genetics at Ohio State and the OSUCCC – James.

Some more progress in James-led research. We’ve got to keep ahead of this stuff..

New Emergency Department at The James

The new James/Wexner will have an Emergency Department geared towards  the special conditions experienced by cancer patients.

Read More

Optimization WordPress Plugins & Solutions by W3 EDGE
Optimization WordPress Plugins & Solutions by W3 EDGE